Skip to content

Twitter Linkedin Instagram

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

30 April, Top 20 Shareholders

Top_Holders_Report (2)

Categories: News & Announcements 2019, Top 20 ShareholdersBy PharmAust May 6, 2019

Related posts

29 November, Top 20 Shareholders
December 2, 2019

Pitt Street Research Life Science Conference: Investor Presentation
November 28, 2019

Appendix 3B, Exercise of Options
November 19, 2019

Appendix 3B – Exercise of Options
November 8, 2019

Progress in Recruitment for Phase II Trial in Dogs
November 4, 2019

Appendix 4C and Quarterly Update
November 1, 2019

Recent Articles

29 November, Top 20 Shareholders
December 2, 2019
Pitt Street Research Life Science Conference: Investor Presentation
November 28, 2019
Appendix 3B, Exercise of Options
November 19, 2019
Appendix 3B – Exercise of Options
November 8, 2019

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

DOGS WITH CANCER NEEDED FOR FREE CLINICAL TRIAL.

PharmAust is currently recruiting dogs with B cell lymphoma for a Phase II clinical trial with a non-toxic anti cancer drug.

https://t.co/YVnCm8v1eT

Reply on Twitter 1202055661439205376 Retweet on Twitter 12020556614392053762 Like on Twitter 12020556614392053765 Twitter 1202055661439205376

Copyright © 2019 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions